# Syndax Pharmaceuticals

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/syndax-pharmaceuticals/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | business |
| OpenAlex ID | https://openalex.org/F4320317987 |
| Works | 601 |

## Funder papers

- [<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes](https://scholariq.org/papers/i-egfr-i-mutant-adenocarcinomas-that-transform-to-small-cell-lung-cancer-and/)
- [Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial](https://scholariq.org/papers/efficacy-and-safety-of-niraparib-in-patients-aged-65-years-and-older-with/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.